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LETTERS TO THE EDITOR
To the Editor:
I read the paper of Herbert A. Goldfarb (Goldfarb
HA. Combining Myoma Coagulation with Endo-
metrial Ablation/Resection Reduces Subsequent
Surgery Rates. JSLS. 1999;3;253-260) with great inter-
est.
Hysteroscopic myomectomy was found to be suc-
cessful in treating menstrual symptoms caused by
submucous fibroids in four out of five cases.1
I have personally performed 112 endometrial resec-
tions between 1993 and 1996 of which the patients
had submucosal fibroid(s) in 30 cases. Apart from
two patients who wanted to conceive, the rest had
endometrial resection as well as myomectomy. The
fibroids were removed with a fibroid resectoscope
(Karl Storz GmbH, Tutlingen, Germany) that had the
capability of using a needle (instead of the loop or
ball electrode) to inject anesthetic into the fundal
area. This made it possible to perform the operation
under local anesthesia (8% of the cases). The tech-
nique has been reported in the literature.2 Although
my study population is similar to only a part of the
patients in Goldfarb’s paper (resection and myolysis
group), the comparison is edifying. There was only
one point where I found a significant difference,
namely the percentage of patients who needed fur-
ther hysterectomy (17% versus 3.5%). 
What are the reasons for this difference?
The follow-up period of my study was longer – 69
months (range, 38 to 86). Fifty percent of the patients
who needed subsequent hysterectomy underwent
the procedure within 24 months. The need for fur-
ther surgery decreased with time. There were no
patients in my study group who had repeated
endometrial resection or myoma enucleation, but all
of them had abdominal hysterectomy. The decision
for additional surgery was not made by the surgeon
who performed the endometrial ablation, but by
those who referred the patient for the initial proce-
dure to our center.
There are two reasons noted for our difference. The
first one is the longer follow-up period (69 versus 33
months), and the second reason is that the decision
regarding long term management of the patients in
my study group was not in my hands, but in those
who referred the patients for operation to our center.
Although in Goldfarb’s study almost the same per-
centage of patients (18%) had further surgery due to
inadequate symptomatic relief, only one patient
(3.5%) had a hysterectomy.
It seems to be very important that the patient has to
be followed by the same surgeon who performed the
initial hysteroscopic procedure. In this way, even if
further operative treatment is required, the treatment
could be a repeated hysteroscopic, minimally invasive
procedure, instead of a hysterectomy.
Sincerely,
Bela G. Molnár MD, PhD
Department of Obstetrics and Gynecology, Albert
Szent-Gyorgyi Medical and Pharmaceutical Center,
University of Sciences Szeged, Hungary.
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